NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-19-132 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-19-004 from the NIH Guide for Grants and Contracts. The purpose of the NIEHS/DOE Nuclear Worker Training Program is to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response within the DOE nuclear weapons complex.
Notice NOT-AT-19-033 from the NIH Guide for Grants and Contracts
Notice NOT-DA-19-065 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HL-20-030 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans. Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ
Funding Opportunity PAR-19-344 from the NIH Guide for Grants and Contracts. EXplainable Artificial Intelligence (XAI) aims to provide strong predictive value along with mechanistic understanding by combining machine learning techniques with effective explanatory techniques. This Funding Opportunity Announcement (FOA) solicits applications in the area of XAI applied to neuroscientific questions of encoding, decoding, and modulation of neural circuits linked to behavior. This FOA encourages collaborations between computationally and experimentally-focused investigators. This FOA seeks machine learning algorithms able to mechanistically explain how experimental manipulations can improve cognitive, affective, or social processing in humans or animals. Proof-of-concept applications aimed at improving the current state of the technology that use XAI to provide unbiased, hierarchical explanations of causal relationships between complex neural and behavioral data are also responsive.
Funding Opportunity RFA-AG-20-031 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support short courses geared to behavioral and social scientists who have existing expertise in aging research and can make research contributions in Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) with additional knowledge about the diseaseand related research resources. Fields of behavioral and social science research relevant for this FOA are health economics, labor economics, health services research, healthcare policy, public policy, demography, sociology, social epidemiology, psychology, and social neuroscience. Priority areas of focus include, but are not limited to, the following: dementia care; dementia caregiver research; cognitive and dementia epidemiology; behavioral and social pathways of AD/ADRD; role of social, contextual, environmental, and institutional factors in AD/ADRD; early psychological changes preceding AD/ADRD onset; prevention of AD/ADRD; disparities in AD/ADRD or dementia-related outcomes; and research resources and methods for studying the determinants and impact of AD/ADRD.
Notice NOT-AT-19-032 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-134 from the NIH Guide for Grants and Contracts
Notice NOT-HL-19-717 from the NIH Guide for Grants and Contracts
Notice NOT-HL-19-716 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-339 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Funding Opportunity PAR-19-340 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimers Disease
Notice NOT-AG-19-033 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-338 from the NIH Guide for Grants and Contracts. This FOA invites revision, resubmission, or renewal applications to the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement. Revision applications may not request funding beyond the project end date of the Parent award.
Notice NOT-NR-19-009 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-008 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-007 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HL-20-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to identify abnormalities in circadian-ordered gene expression to improve our understanding of disease phenotypes, etiology, risk stratification, resilience, and therapeutic management in diseases.
Notice NOT-GM-19-056 from the NIH Guide for Grants and Contracts